Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

Sean Z. Zhao, MD, PhD;Thomas A. Burke, PharmD, MPH;Andrew Whelton, MD, PhD;Heather von Allmen;Scott C. Henderson, MS;

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

October 1, 2002

Sean Z. Zhao, MD, PhD, Thomas A. Burke, PharmD, MPH, Andrew Whelton, MD, PhD, Heather von Allmen, Scott C. Henderson, MS

Supplements and Featured Publications, Cardiorenal Differences Among NSAIDs and Coxibs: Real-World Experience, Volume 8, Issue 15 Suppl